Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis.

Autor: Cheung BB; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia. bcheung@ccia.unsw.edu.au.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia. bcheung@ccia.unsw.edu.au., Mittra R; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Murray J; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Wang Q; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Seneviratne JA; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Raipuria M; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Wong IPL; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Restuccia D; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Gifford A; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Salib A; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Sutton S; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Huang L; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Ferdowsi PV; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Tsang J; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Sekyere E; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia., Mayoh C; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia., Luo L; Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia., Brown DL; Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia., Stow JL; Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia., Zhu S; Department of Biochemistry and Molecular Biology, Cancer Center and Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA., Young RJ; Peter MacCallum Cancer Centre, Melbourne, Australia., Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Australia., Chappaz S; Anatomy & Developmental Biology, Monash University, Melbourne, Australia., Kile B; Faculty of Health and Medical Sciences at the University of Adelaide, Adelaide, Australia., Kueh A; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Victoria, 3052, Australia., Herold MJ; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Victoria, 3052, Australia., Hilton DJ; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Victoria, 3052, Australia., Liu T; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia.; University of New South Wales Centre for Childhood Cancer Research, Sydney, NSW 2052, Australia., Norris MD; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia.; University of New South Wales Centre for Childhood Cancer Research, Sydney, NSW 2052, Australia., Haber M; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia., Carter DR; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia.; School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia., Parker MW; ACRF Facility for Innovative Cancer Drug Discovery and Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Marshall GM; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia. glenn.marshall@health.nsw.gov.au.; Kids Cancer Centre, Sydney Children's Hospital, Sydney, 2031, NSW, Australia. glenn.marshall@health.nsw.gov.au.

Publikováno v: Communications biology [Commun Biol] 2024 Oct 14; Vol. 7 (1), pp. 1322. Date of Electronic Publication: 2024 Oct 14.

MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression.

Autor: Salib A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, 2052, Australia.; School of Women's and Children's Health, UNSW Sydney, Kensington, NSW, 2052, Australia., Jayatilleke N; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, 2052, Australia., Seneviratne JA; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, 2052, Australia., Mayoh C; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, 2052, Australia.; School of Women's and Children's Health, UNSW Sydney, Kensington, NSW, 2052, Australia., De Preter K; Center for Medical Genetics (CMGG), Ghent University, Medical Research Building (MRB1), Ghent, Belgium., Speleman F; Center for Medical Genetics (CMGG), Ghent University, Medical Research Building (MRB1), Ghent, Belgium., Cheung BB; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, 2052, Australia.; School of Women's and Children's Health, UNSW Sydney, Kensington, NSW, 2052, Australia., Carter DR; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, 2052, Australia. Daniel.Carter@uts.edu.au.; School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, 2007, Australia. Daniel.Carter@uts.edu.au., Marshall GM; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, 2052, Australia. glenn.marshall@health.nsw.gov.au.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, 2031, Australia. glenn.marshall@health.nsw.gov.au.

Publikováno v: Oncogene [Oncogene] 2024 Jan; Vol. 43 (5), pp. 363-377. Date of Electronic Publication: 2023 Dec 04.

Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma.

Autor: Seneviratne JA; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia., Carter DR; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia.; School of Biomedical Engineering, University of Technology Sydney, New South Wales, Australia., Mittra R; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Gifford A; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia., Kim PY; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Luo JS; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; Department of Paediatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Mayoh C; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia., Salib A; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia., Rahmanto AS; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Murray J; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Cheng NC; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Nagy Z; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Wang Q; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Kleynhans A; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia., Tan O; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Sutton SK; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Xue C; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Chung SA; Adult Cancer Program, Lowy Cancer Research Centre, UNSW Sydney, New South Wales, Australia., Zhang Y; Department of Paediatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; Department of Paediatric Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, Guangdong, China., Sun C; Department of Paediatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; Department of Paediatric Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, Guangdong, China., Zhang L; Department of Paediatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; Department of Paediatric Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, Guangdong, China., Haber M; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia., Norris MD; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; University of New South Wales, Centre for Childhood Cancer Research, Randwick, New South Wales, Australia., Fletcher JI; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia., Liu T; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia., Dilda PJ; Adult Cancer Program, Lowy Cancer Research Centre, UNSW Sydney, New South Wales, Australia., Hogg PJ; Australian Cancer Research Foundation (ACRF), Centenary Cancer Research Centre, Charles Perkins Centre, University of Sydney, New South Wales, Australia., Cheung BB; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia.; Department of Paediatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Marshall GM; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, New South Wales, Australia.; School of Women's & Children's Health, UNSW Sydney, New South Wales, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.

Publikováno v: International journal of cancer [Int J Cancer] 2023 Apr 01; Vol. 152 (7), pp. 1399-1413. Date of Electronic Publication: 2022 Nov 17.

The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression.

Autor: Xiao L; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia., Karsa M; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia., Ronca E; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia., Bongers A; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia., Kosciolek A; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia., El-Ayoubi A; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia., Revalde JL; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; Australian Cancer Research Foundation (ACRF) Drug Discovery Centre for Childhood Cancer, Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia., Seneviratne JA; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia., Cheung BB; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia., Cheung LC; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; Curtin Medical School, Curtin University, Perth, WA, Australia.; Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia., Kotecha RS; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; Curtin Medical School, Curtin University, Perth, WA, Australia.; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia.; Division of Paediatrics, School of Medicine, University of Western Australia, Perth, WA, Australia., Newbold A; Gene Regulation Laboratory, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Bjelosevic S; Gene Regulation Laboratory, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Arndt GM; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia.; Australian Cancer Research Foundation (ACRF) Drug Discovery Centre for Childhood Cancer, Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia., Lock RB; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia., Johnstone RW; Gene Regulation Laboratory, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Gudkov AV; Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, United States., Gurova KV; Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, United States., Haber M; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia., Norris MD; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia.; University of New South Wales Centre for Childhood Cancer Research, Sydney, NSW, Australia., Henderson MJ; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia., Somers K; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 May 23; Vol. 12, pp. 863329. Date of Electronic Publication: 2022 May 23 (Print Publication: 2022).

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.

Autor: Van Thillo Q; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium.; Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven, Belgium., De Bie J; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium.; Center for Human Genetics, UZ Leuven, Leuven, Belgium., Seneviratne JA; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia., Demeyer S; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium.; Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven, Belgium., Omari S; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia., Balachandran A; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia., Zhai V; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia., Tam WL; Technology Innovation Lab, VIB, Gent, Belgium., Sweron B; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium., Geerdens E; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium.; Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven, Belgium., Gielen O; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium., Provost S; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Center for Cancer Biology, VIB, Leuven, Belgium., Segers H; Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Pediatric Hemato-Oncology, UZ Leuven, Leuven, Belgium., Boeckx N; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium., Marshall GM; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia., Cheung BB; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia., Isobe K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kato I; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Takita J; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Amos TG; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia., Deveson IW; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia., McCalmont H; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia., Lock RB; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia., Oxley EP; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Garwood MM; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Dickins RA; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Uyttebroeck A; Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Pediatric Hemato-Oncology, UZ Leuven, Leuven, Belgium., Carter DR; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia.; School of Biomedical Engineering, University of Technology, Sydney, NSW, Australia., Cools J; Department of Human Genetics, KU Leuven, Leuven, Belgium. jan.cools@kuleuven.be.; Center for Cancer Biology, VIB, Leuven, Belgium. jan.cools@kuleuven.be.; Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven, Belgium. jan.cools@kuleuven.be., de Bock CE; Children's Cancer Institute, UNSW Sydney, Lowy Cancer Research Centre, Sydney, NSW, Australia. cdebock@ccia.org.au.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia. cdebock@ccia.org.au.

Publikováno v: Nature communications [Nat Commun] 2021 Jul 06; Vol. 12 (1), pp. 4164. Date of Electronic Publication: 2021 Jul 06.